MarketPeel
Insider Trading Intelligence
Pricing
…
SB

Steven Keith Burke

AKBA
SVP, CHIEF MEDICAL OFFICER · AKEBIA THERAPEUTICS, INC. · CIK 0001619834
FILING MIX · LIFETIME44%/56%
BUYS
17
SELLS
22
TOTAL VALUE
$460.8K
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
948,432
AVG SELL PX
$1.52
TRADE KIND
SHOWING 39 / 39
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
17 backtested trades · 8 horizons · 12 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Steven Keith Burke, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d17+41.18%+4.49%+0.18%+4.31%+7.31%—
14d17+70.59%-5.25%+0.21%-5.46%-11.24%—
30d17+70.59%-10.78%+0.22%-11.00%-7.94%—
60d17+70.59%-11.00%-1.49%-9.51%-10.27%—
90d17+41.18%-4.76%+2.64%-7.40%-2.08%—
180d17(3 pending)+50.00%+22.10%+7.99%+14.10%-2.71%—
1y17(3 pending)+50.00%+11.25%+16.09%-4.84%-28.49%—
2y17(6 pending)+63.64%+36.73%+32.67%+4.06%-54.25%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AKBA · 948,432 shares · as of Feb 2, 2026
0254,023508,045762,0681,016,090202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 17 buys / 22 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AKBA
AKEBIA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
21,582$1.39$30.0K994,508Feb 2, 2026Feb 4, 2026 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
25,375$1.39$35.3K969,133Feb 2, 2026Feb 4, 2026 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
20,701$1.39$28.8K948,432Feb 2, 2026Feb 4, 2026 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
204,000——1,016,090Jan 30, 2026Feb 3, 2026 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
320,000——320,000Jan 30, 2026Feb 3, 2026 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,144$1.83$13.1K809,090Mar 3, 2025Mar 4, 2025 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
23,270$2.10$48.9K843,470Feb 3, 2025Feb 4, 2025 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
27,236$2.10$57.2K816,234Feb 3, 2025Feb 4, 2025 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
194,900——866,740Jan 31, 2025Feb 4, 2025 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
292,300——292,300Jan 31, 2025Feb 4, 2025 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
7,169$1.58$11.3K695,840Feb 29, 2024Mar 1, 2024 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,367$1.52$12.7K703,009Feb 27, 2024Feb 29, 2024 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
24,311$1.68$40.8K711,376Feb 1, 2024Feb 2, 2024 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
303,300——303,300Jan 31, 2024Feb 2, 2024 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
202,200——735,687Jan 31, 2024Feb 2, 2024 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
27,000$1.15$31.1K668,840Aug 25, 2023May 9, 2024 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
63,567$1.07$67.9K530,487May 16, 2023May 18, 2023 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
6,400$0.88$5.6K595,164Mar 1, 2023Mar 3, 2023 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
6,613$0.88$5.8K601,564Mar 1, 2023Mar 3, 2023 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
1,110$0.88$974594,054Mar 1, 2023Mar 3, 2023 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
7,539$0.81$6.1K608,177Feb 27, 2023Mar 1, 2023 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
196,200——615,716Jan 31, 2023Feb 2, 2023 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
294,300——294,300Jan 31, 2023Feb 2, 2023 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
1,147$0.36$416418,016Aug 31, 2022Sep 1, 2022 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——417,663May 12, 2022May 16, 2022 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000May 12, 2022May 16, 2022 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
6,556$2.17$14.2K217,263Mar 1, 2022Mar 2, 2022 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
1,100$2.17$2.4K217,663Mar 1, 2022Mar 2, 2022 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
7,400$2.15$15.9K163,819Feb 28, 2022Mar 2, 2022 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
225,000——225,000Feb 28, 2022Mar 2, 2022 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,000——223,819Feb 28, 2022Mar 2, 2022 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
1,042$2.83$2.9K171,219Aug 31, 2021Sep 2, 2021 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
1,081$3.40$3.7K170,761Apr 1, 2021Apr 1, 2021 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,400——171,842Mar 16, 2021Mar 18, 2021 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
SALE
SVP, Chief Medical Officer
7,558$3.40$25.7K161,442Mar 1, 2021Mar 2, 2021 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
70,000——169,000Feb 26, 2021Mar 2, 2021 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
120,000——120,000Feb 26, 2021Mar 2, 2021 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
105,500——105,500Feb 28, 2020Mar 2, 2020 ↗View →
AKBA
AKEBIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
62,000——99,000Feb 28, 2020Mar 2, 2020 ↗View →
Other insiders · AKBA
Loading peer insiders…
About this filer
CIK 0001619834
ROLE
SVP, Chief Medical Officer
PRIMARY
AKBA
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001619834DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback